Eagle Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Eagle Asset Management's RMD Position: Q2 2023 in Review
Eagle Asset Management sold out of ResMed (RMD) in Q2 2023, closing a stake of 257,156 shares — an estimated $56.3M sold.
Eagle Asset Management first reported a position in RMD in Q2 2013 and held it in 16 quarters. The position peaked at $113M in Q1 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.
- Eagle Asset Management reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
- Eagle Asset Management sold 257,156 ResMed shares in Q2 2023, an estimated $56.3M.
- Eagle Asset Management first reported a position in ResMed in Q2 2013 and held it in 16 quarters.
- Eagle Asset Management's ResMed position peaked at $113M in Q1 2022.
- 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.
Based on Eagle Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.